Education
About Us
Working with TipRanks
Follow Us
AstraZeneca plc (SE:AZN)
:AZN
AZN Analyst Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AZN Stock 12 Month Forecast
Average Price Target
kr1,788.59
▲(15.13% Upside)
| Highest Price Targetkr2,463 | Average Price Targetkr1,789 | Lowest Price Targetkr1,413 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
Shore Capital
Reiterated
03/07/25
Bernstein
Reiterated
03/04/25
J.P. Morgan
Reiterated
02/26/25
Goldman Sachs
Reiterated
02/26/25
Berenberg Bank
Reiterated
02/25/25
Deutsche Bank
Reiterated
02/12/25
DZ BANK AG
Reiterated
02/07/25
Jefferies
kr1,412.83
Hold
-9.05%
Downside
Reiterated
02/06/25
AstraZeneca (AZN) Gets a Hold from Jefferies
Barclays
kr1,814.65
Buy
16.81%
Upside
Reiterated
02/05/25
AstraZeneca (AZN) Gets a Buy from Barclays
Guggenheim
kr1,698.21
Buy
9.31%
Upside
Reiterated
01/29/25
Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
Stifel Nicolaus
kr1,827.84
Buy
17.66%
Upside
Reiterated
11/13/24
AstraZeneca: Strong Q3 Growth and Strategic Moves Justify Buy Rating
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
Shore Capital
Reiterated
03/07/25
Bernstein
Reiterated
03/04/25
J.P. Morgan
Reiterated
02/26/25
Goldman Sachs
Reiterated
02/26/25
Berenberg Bank
Reiterated
02/25/25
Deutsche Bank
Reiterated
02/12/25
DZ BANK AG
Reiterated
02/07/25
Jefferies
kr1,412.83
Hold
-9.05%
Downside
Reiterated
02/06/25
AstraZeneca (AZN) Gets a Hold from Jefferies
Barclays
kr1,814.65
Buy
16.81%
Upside
Reiterated
02/05/25
AstraZeneca (AZN) Gets a Buy from Barclays
Guggenheim
kr1,698.21
Buy
9.31%
Upside
Reiterated
01/29/25
Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
Stifel Nicolaus
kr1,827.84
Buy
17.66%
Upside
Reiterated
11/13/24
AstraZeneca: Strong Q3 Growth and Strategic Moves Justify Buy Rating
Best Analysts Covering AstraZeneca
Which Analyst Should I Follow If I Want to Buy SE:AZN and Sell After:
1 Month
xxx
Success Rate
22/40 ratings generated profit
Average Return
+2.20%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.00% of your transactions generating a profit, with an average return of +2.20% per trade.
3 Months
xxx
Success Rate
24/40 ratings generated profit
Average Return
+3.94%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +3.94% per trade.
1 Year
Success Rate
27/30 ratings generated profit
Average Return
+15.35%
reiterated a buy rating 3 days ago
Copying Matthew Weston's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +15.35% per trade.
2 Years
xxx
Success Rate
27/30 ratings generated profit
Average Return
+24.04%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +24.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AZN Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
2
1
1
0
0
Buy
34
21
29
31
34
Hold
9
10
11
12
9
Sell
2
0
0
0
0
Strong Sell
5
3
3
0
0
total
52
35
44
43
43
Each month's total comprises the sum of three months' worth of ratings.
AZN Financial Forecast
AZN Stock Forecast FAQ
What is SE:AZN’s average 12-month price target, according to analysts?
Based on analyst ratings, AstraZeneca plc’s 12-month average price target is kr1,788.59.
What is SE:AZN’s upside potential, based on the analysts’ average price target?
AstraZeneca plc has 15.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AstraZeneca plc a Buy, Sell or Hold?
AstraZeneca plc has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is AstraZeneca plc’s share price target?
The average share price target for AstraZeneca plc is kr1,788.59. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr2,463.05 ,and the lowest forecast is kr1,413.01. The average share price target represents 15.13% Increase from the current price of kr1,553.5.
The highest analyst share price target is kr2,463.05 ,and the lowest forecast is kr1,413.01. The average share price target represents 15.13% Increase from the current price of kr1,553.5.
What do analysts say about AstraZeneca plc?
AstraZeneca plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of AstraZeneca plc?
To buy shares of SE:AZN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.